In our analysis of genetic mutations, HR+ patients had more ATM mutations, and a high expression level of ATM has been reported to be associated with an increased risk of pancancer, including breast cancer, and may lead to chemotherapy resistance.25, 26. Here, ATM is linked to breast cancer.